Listed by the USPTO as GOLOVAN, MARK
Tech Center 3700 • Art Units: 3783
This examiner grants 67% of resolved cases
This examiner is assigned to tech center 3700 and art unit 3783. The profile includes 3 resolved cases, with an allowance rate of 66.7% and a median of 961 days to allowance. The interview lift is 50.0%, but the small case history makes the apparent interview association directional.
The listed companies are Shl Medical AG, Boston Scientific Corporation, and Cardinal Health Inc. The principal firms are MCDONNELL BOEHNEN HULBERT & BERGHOFF LLP, Bond, Schoeneck & King, PLLC - SANOFI, and FERGUSON CASE ORR PATERSON LLP. Practitioners should avoid broad predictions and evaluate each matter on its own prosecution record while considering interviews as a possible tool.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18236132 | Vascular Access Instrument | Final Rejection | Becton, Dickinson and Company |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy66.7% of resolved applications examined by Mark Golovan were allowed (3 resolved cases), compared with 67.3% across Art Unit 3783 over the last five years.
This examiner's interview lift is +50.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Mark Golovan took 961 days on average from filing to allowance.
Mark Golovan examines applications in Art Unit 3783 in Tech Center 3700 (Medical Devices & Mechanical Engineering).
